Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.
Influence of myelinated retinal nerve fibers on retinal vessel density measurement with AngioVue OCT angiography.
Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs.
Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis.
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
Plaque-like demyelination in acute disseminated encephalomyelitis (ADEM) - an autopsy case report.
Objectively Quantified Physical Activity in Persons with Multiple Sclerosis.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells.
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
Multiple sclerosis and the role of immune cells.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Neuroinflammation: no rose by any other name.
The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Presentation of multiple sclerosis with comorbid Huntington's disease.
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Direct MRI detection of impending plaque development in multiple sclerosis.
Evolution of myelin ultrastructure and the major structural myelin proteins.
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
Erratum.
Pages
« first
‹ previous
…
617
618
619
620
621
622
623
624
625
…
next ›
last »